Anti-inflammatory therapy with tumour necrosis factor inhibitors is associated with reduced risk of major adverse cardiovascular events in psoriasis
Journal of the European Academy of Dermatology and Venereology | May 10, 2018
Most read this week
Journal of the European Academy of Dermatology and Venereology | May 10, 2018